Breaking News Instant updates and real-time market news.

LULU

Lululemon

$280.35 /

-3.3 (-1.16%)

06:55
07/07/22
07/07
06:55
07/07/22
06:55

Lululemon remains durable growth name in volatile period, says Baird

Baird analyst Mark Altschwager said Lululemon remains a durable growth name in a volatile period, supported by continued innovation and a higher-income consumer profile. He noted June assortment and newness growth saw modest sequential deceleration, but newness growth continues to outpace overall assortment, leading to a sequential increase in new "mix". Altschwager reiterated his Outperform rating and $430 price target on Lululemon shares.

OTHER BREAKING NEWS FROM THE FLY

Earnings
Silver Spike Investment reports Q1 NII 4c vs. ($425.03) last year » 07:10
08/12/22
08/12
07:10
08/12/22
07:10
SSIC

Silver Spike Investment

$8.86 /

-0.33 (-3.59%)

Net asset value per share…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SSIC Silver Spike Investment
$8.86 /

-0.33 (-3.59%)

03/01/22 Piper Sandler
Silver Spike Investment initiated with an Overweight at Piper Sandler
03/01/22 Stifel
Silver Spike Investment initiated with a Hold at Stifel
  • 04
    Feb
Earnings
Instil Bio reports Q2 adjusted EPS (40c), consensus (41c) » 07:08
08/12/22
08/12
07:08
08/12/22
07:08
TIL

Instil Bio

$6.79 /

+0.09 (+1.34%)

As of June 30, 2022, we…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TIL Instil Bio
$6.79 /

+0.09 (+1.34%)

TIL Instil Bio
$6.79 /

+0.09 (+1.34%)

06/05/22 Morgan Stanley
Instil Bio price target lowered to $9 from $14 at Morgan Stanley
08/13/21 Baird
Baird sees likely success for Instil Bio lead candidate, starts at Outperform
08/12/21 Baird
Instil Bio initiated with an Outperform at Baird
TIL Instil Bio
$6.79 /

+0.09 (+1.34%)

TIL Instil Bio
$6.79 /

+0.09 (+1.34%)

Hot Stocks
Rapid Micro Biosystems adopts stockholder rights plan » 07:08
08/12/22
08/12
07:08
08/12/22
07:08
RPID

Rapid Micro Biosystems

$4.21 /

-0.03 (-0.71%)

Rapid Micro Biosystems…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

10/14/21 Cowen
Rapid Micro Biosystems coverage transferred at Cowen
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

Hot Stocks
Rapid Micro Biosystems announces review of strategic alternatives » 07:07
08/12/22
08/12
07:07
08/12/22
07:07
RPID

Rapid Micro Biosystems

$4.21 /

-0.03 (-0.71%)

Rapid Micro Biosystems…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

10/14/21 Cowen
Rapid Micro Biosystems coverage transferred at Cowen
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

Recommendations
Marriott Vacations price target lowered to $202 from $205 at Truist » 07:07
08/12/22
08/12
07:07
08/12/22
07:07
VAC

Marriott Vacations

$146.63 /

+1.64 (+1.13%)

Truist analyst Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VAC Marriott Vacations
$146.63 /

+1.64 (+1.13%)

VAC Marriott Vacations
$146.63 /

+1.64 (+1.13%)

08/10/22 Barclays
Marriott Vacations price target raised to $165 from $136 at Barclays
08/10/22 Deutsche Bank
Marriott Vacations price target raised to $192 from $188 at Deutsche Bank
06/28/22 Barclays
Barclays says shift in preferences to cushion Gaming, Cruises, Timeshare names
06/28/22 Barclays
Marriott Vacations initiated with an Overweight at Barclays
VAC Marriott Vacations
$146.63 /

+1.64 (+1.13%)

Recommendations
Travel + Leisure price target lowered to $72 from $78 at Truist » 07:07
08/12/22
08/12
07:07
08/12/22
07:07
TNL

Travel + Leisure

$45.78 /

+0.795 (+1.77%)

Truist analyst C. Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TNL Travel + Leisure
$45.78 /

+0.795 (+1.77%)

TNL Travel + Leisure
$45.78 /

+0.795 (+1.77%)

08/01/22 Deutsche Bank
Travel + Leisure price target lowered to $69 from $76 at Deutsche Bank
07/28/22 Stifel
Travel + Leisure price target lowered to $61 from $76 at Stifel
06/28/22 Barclays
Travel + Leisure initiated with an Equal Weight at Barclays
04/29/22 Jefferies
Travel + Leisure upgraded to Buy at Jefferies after positive headline results
TNL Travel + Leisure
$45.78 /

+0.795 (+1.77%)

Recommendations
Hilton Grand Vacations price target lowered to $63 from $64 at Truist » 07:07
08/12/22
08/12
07:07
08/12/22
07:07
HGV

Hilton Grand Vacations

$43.49 /

-0.17 (-0.39%)

Truist analyst C. Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HGV Hilton Grand Vacations
$43.49 /

-0.17 (-0.39%)

HGV Hilton Grand Vacations
$43.49 /

-0.17 (-0.39%)

06/28/22 Barclays
Barclays says shift in preferences to cushion Gaming, Cruises, Timeshare names
06/28/22 Barclays
Hilton Grand Vacations initiated with an Overweight at Barclays
03/08/22 Truist
Hilton Grand Vacations price target raised to $63 from $60 at Truist
12/06/21 Truist
Hilton Grand Vacations price target raised to $60 from $54 at Truist
HGV Hilton Grand Vacations
$43.49 /

-0.17 (-0.39%)

Earnings
Applied Therapeutics reports Q2 EPS (96c), consensus (78c) » 07:06
08/12/22
08/12
07:06
08/12/22
07:06
APLT

Applied Therapeutics

$1.31 /

+0.09 (+7.38%)

Cash and cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APLT Applied Therapeutics
$1.31 /

+0.09 (+7.38%)

APLT Applied Therapeutics
$1.31 /

+0.09 (+7.38%)

04/13/22 Truist
Applied Therapeutics price target lowered to $6 from $85 at Truist
03/21/22 Barclays
Applied Therapeutics price target lowered to $2.50 from $7 at Barclays
01/05/22 Citi
Applied Therapeutics price target lowered to $30 from $38 at Citi
01/04/22 Goldman Sachs
Applied Therapeutics price target lowered to $3 from $10 at Goldman Sachs
APLT Applied Therapeutics
$1.31 /

+0.09 (+7.38%)

  • 23
    Jun
APLT Applied Therapeutics
$1.31 /

+0.09 (+7.38%)

Recommendations
Bluegreen Vacations price target lowered to $56 from $57 at Truist » 07:06
08/12/22
08/12
07:06
08/12/22
07:06
BVH

Bluegreen Vacations

$23.67 /

+0.01 (+0.04%)

Truist analyst C. Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BVH Bluegreen Vacations
$23.67 /

+0.01 (+0.04%)

BVH Bluegreen Vacations
$23.67 /

+0.01 (+0.04%)

03/08/22 Truist
Bluegreen Vacations price target raised to $56 from $44 at Truist
11/16/21 Truist
Bluegreen Vacations price target raised to $44 from $41 at Truist
11/05/21 B. Riley
Bluegreen Vacations price target raised to $59 from $42.50 at B. Riley
09/29/21 Truist
Bluegreen Vacations Holding assumed with a Buy at Truist
BVH Bluegreen Vacations
$23.67 /

+0.01 (+0.04%)

Hot Stocks
Rapid Micro Biosystems rejects non-binding proposal from Kennedy Lewis » 07:06
08/12/22
08/12
07:06
08/12/22
07:06
RPID

Rapid Micro Biosystems

$4.21 /

-0.03 (-0.71%)

In addition, the Company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

10/14/21 Cowen
Rapid Micro Biosystems coverage transferred at Cowen
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

Downgrade
TIS Inc. downgraded to Neutral from Buy at Citi » 07:06
08/12/22
08/12
07:06
08/12/22
07:06
TISNF

TIS Inc.

/

+

Citi analyst Mitsunobu…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TISNF TIS Inc.
/

+

05/26/22 Jefferies
TIS Inc. downgraded to Hold from Buy at Jefferies
12/14/21 Daiwa
TIS Inc. upgraded to Outperform from Neutral at Daiwa
10/01/21 Credit Suisse
TIS Inc. downgraded to Neutral from Outperform at Credit Suisse
09/17/21 Daiwa
TIS Inc. downgraded to Neutral from Outperform at Daiwa
Recommendations
System1 price target lowered to $13 from $15 at Benchmark » 07:06
08/12/22
08/12
07:06
08/12/22
07:06
SST

System1

$8.69 /

+0.045 (+0.52%)

Benchmark analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SST System1
$8.69 /

+0.045 (+0.52%)

SST System1
$8.69 /

+0.045 (+0.52%)

07/11/22 BofA
BofA starts System1 at Buy with $12 price target
07/11/22 BofA
System1 initiated with a Buy at BofA
04/26/22 Evercore ISI
System1 initiated with an In Line at Evercore ISI
04/06/22 DA Davidson
System1 price target raised to $26 from $23 at DA Davidson
SST System1
$8.69 /

+0.045 (+0.52%)

SST System1
$8.69 /

+0.045 (+0.52%)

SST System1
$8.69 /

+0.045 (+0.52%)

Hot Stocks
Iterum Therapeutics expects cash to fund operations into 2024 » 07:05
08/12/22
08/12
07:05
08/12/22
07:05
ITRM

Iterum Therapeutics

$0.25 /

+0.0007 (+0.28%)

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ITRM Iterum Therapeutics
$0.25 /

+0.0007 (+0.28%)

ITRM Iterum Therapeutics
$0.25 /

+0.0007 (+0.28%)

Earnings
Iterum Therapeutics reports Q2 adjusted EPS (3c) vs (4c) last year » 07:05
08/12/22
08/12
07:05
08/12/22
07:05
ITRM

Iterum Therapeutics

$0.25 /

+0.0007 (+0.28%)

"We are excited to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ITRM Iterum Therapeutics
$0.25 /

+0.0007 (+0.28%)

ITRM Iterum Therapeutics
$0.25 /

+0.0007 (+0.28%)

Earnings
Casi Pharmaceuticals reports Q2 EPS (56c), consensus (64c) » 07:05
08/12/22
08/12
07:05
08/12/22
07:05
CASI

Casi Pharmaceuticals

$3.91 /

+0.91 (+30.33%)

Reports Q2 revenue $8.6M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CASI Casi Pharmaceuticals
$3.91 /

+0.91 (+30.33%)

CASI Casi Pharmaceuticals
$3.91 /

+0.91 (+30.33%)

06/03/22 BTIG
Casi Pharmaceuticals price target adjusted to $21 at BTIG after 1 for 10 split
05/26/22 Oppenheimer
Casi Pharmaceuticals should benefit from Shanghai's reopening, says Oppenheimer
05/13/22 H.C. Wainwright
Casi Pharmaceuticals price target lowered to $3 from $4 at H.C. Wainwright
CASI Casi Pharmaceuticals
$3.91 /

+0.91 (+30.33%)

Hot Stocks
Rapid Micro Biosystems CCO Andy Keys departs » 07:05
08/12/22
08/12
07:05
08/12/22
07:05
RPID

Rapid Micro Biosystems

$4.21 /

-0.03 (-0.71%)

In connection with the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

10/14/21 Cowen
Rapid Micro Biosystems coverage transferred at Cowen
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

Earnings
Fennec reports Q2 EPS (19c), consensus (14c) » 07:05
08/12/22
08/12
07:05
08/12/22
07:05
FENC

Fennec

$6.99 /

+0.07 (+1.01%)

Cash and cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FENC Fennec
$6.99 /

+0.07 (+1.01%)

FENC Fennec
$6.99 /

+0.07 (+1.01%)

08/08/22 Craig-Hallum
Fennec assumed with a Buy at Craig-Hallum
12/01/21 Maxim
Fennec price target lowered to $10 from $12 at Maxim
11/30/21 Craig-Hallum
Fennec price target lowered to $14 from $19 at Craig-Hallum
FENC Fennec
$6.99 /

+0.07 (+1.01%)

Hot Stocks
Rapid Micro Biosystems announces restructuring plan with 20% workforce reduction » 07:05
08/12/22
08/12
07:05
08/12/22
07:05
RPID

Rapid Micro Biosystems

$4.21 /

-0.03 (-0.71%)

The Company is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

10/14/21 Cowen
Rapid Micro Biosystems coverage transferred at Cowen
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

Earnings
Leap Therapeutics reports Q2 EPS (15c), consensus (10c) » 07:04
08/12/22
08/12
07:04
08/12/22
07:04
LPTX

Leap Therapeutics

$1.32 /

+0.15 (+12.82%)

Cash and cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LPTX Leap Therapeutics
$1.32 /

+0.15 (+12.82%)

LPTX Leap Therapeutics
$1.32 /

+0.15 (+12.82%)

06/06/22 Piper Sandler
Piper says Leap's DKN-01 combo showed 'interesting early signal of activity'
05/27/22 Piper Sandler
Leap Therapeutics price target lowered to $4 from $6 at Piper Sandler
01/23/22 Piper Sandler
Piper ups Leap Therapeutics target to $6 following DKN-01's ASCO GI Update
12/30/21 Mizuho
Mizuho announces top oncology stock picks for 2022
LPTX Leap Therapeutics
$1.32 /

+0.15 (+12.82%)

  • 22
    Sep
Earnings
Rapid Micro Biosystems lowers FY22 revenue view to at least $17M » 07:03
08/12/22
08/12
07:03
08/12/22
07:03
RPID

Rapid Micro Biosystems

$4.21 /

-0.03 (-0.71%)

Consensus $28.01M. The…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

10/14/21 Cowen
Rapid Micro Biosystems coverage transferred at Cowen
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

Earnings
Humacyte reports Q2 EPS 35c, consensus (22c) » 07:03
08/12/22
08/12
07:03
08/12/22
07:03
HUMA

Humacyte

$4.38 /

+0.89 (+25.50%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HUMA Humacyte
$4.38 /

+0.89 (+25.50%)

HUMA Humacyte
$4.38 /

+0.89 (+25.50%)

07/18/22 BTIG
Humacyte price target lowered to $10 from $12 at BTIG
05/15/22 Piper Sandler
Humacyte downgraded to Underweight from Overweight at Piper Sandler
03/29/22 Piper Sandler
Humacyte price target lowered to $10 from $17 at Piper Sandler
10/29/21 Cowen
Humacyte initiated with an Outperform at Cowen
HUMA Humacyte
$4.38 /

+0.89 (+25.50%)

HUMA Humacyte
$4.38 /

+0.89 (+25.50%)

Earnings
Ocuphire Pharma reports Q2 EPS (25c) vs (52c) last year » 07:03
08/12/22
08/12
07:03
08/12/22
07:03
OCUP

Ocuphire Pharma

$2.76 /

+0.405 (+17.23%)

"Ocuphire has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OCUP Ocuphire Pharma
$2.76 /

+0.405 (+17.23%)

OCUP Ocuphire Pharma
$2.76 /

+0.405 (+17.23%)

05/19/22 Alliance Global Partners
Alliance Global Partners says Ocuphire's Nyxol trial run 'remarkable'
11/24/21 H.C. Wainwright
Ocuphire Pharma initiated with a Buy at H.C. Wainwright
10/06/21 Spartan Capital
Ocuphire Pharma initiated with a Buy at Spartan Capital
OCUP Ocuphire Pharma
$2.76 /

+0.405 (+17.23%)

Downgrade
Powszechny Zaklad Ubezpieczen downgraded to Neutral from Buy at Citi » 07:03
08/12/22
08/12
07:03
08/12/22
07:03
PWZYF

Powszechny Zaklad Ubezpieczen

$7.69 /

+ (+0.00%)

Citi analyst Andrzej…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PWZYF Powszechny Zaklad Ubezpieczen
$7.69 /

+ (+0.00%)

06/21/22 JPMorgan
Powszechny Zaklad Ubezpieczen price target lowered to PLN 46.90 at JPMorgan
05/10/22 JPMorgan
PZU price target lowered to PLN 49.25 from PLN 52.75 at JPMorgan
12/14/21 JPMorgan
Powszechny Zaklad Ubezpieczen price target raised to PLN 152.75 at JPMorgan
Earnings
Honest Company sees FY22 revenue growth flat, consensus $318.65M » 07:03
08/12/22
08/12
07:03
08/12/22
07:03
HNST

Honest Company

$3.83 /

+0.005 (+0.13%)

Revenue outlook reflects…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HNST Honest Company
$3.83 /

+0.005 (+0.13%)

HNST Honest Company
$3.83 /

+0.005 (+0.13%)

06/09/22 Loop Capital
Loop Capital cuts Honest Company to Hold amid pressure reported in mass retail
06/09/22 Loop Capital
Honest Company downgraded to Hold from Buy at Loop Capital
05/16/22 Loop Capital
Honest Company price target lowered to $5 from $8 at Loop Capital
03/28/22 Citi
Honest Company shares look 'awfully cheap' after selloff, says Citi
HNST Honest Company
$3.83 /

+0.005 (+0.13%)

HNST Honest Company
$3.83 /

+0.005 (+0.13%)

HNST Honest Company
$3.83 /

+0.005 (+0.13%)

Hot Stocks
Broadridge raises annual dividend 13% to $2.90 from $2.56 per share » 07:02
08/12/22
08/12
07:02
08/12/22
07:02
BR

Broadridge

$169.66 /

-0.745 (-0.44%)

On August 11,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BR Broadridge
$169.66 /

-0.745 (-0.44%)

BR Broadridge
$169.66 /

-0.745 (-0.44%)

08/17/21 JPMorgan
Broadridge price target raised to $197 from $181 at JPMorgan
08/16/21 DA Davidson
Broadridge price target raised to $158 from $152 at DA Davidson
08/13/21 JPMorgan
Broadridge assumed with an Overweight at JPMorgan
BR Broadridge
$169.66 /

-0.745 (-0.44%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.